Unaudited Condensed Consolidated Statements of Changes in Equity - USD ($)	Common Stock	Paid-in Capital	Accumulated Deficits	Non-Controlling Interests	Total
Balance at Dec. 31, 2022	$ 26,500	$ 21,372,100	$ (13,420,400)	$ (1,016,300)	$ 6,961,900
Balance (in Shares) at Dec. 31, 2022	26,484,055
Cumulative-effect adjustment of opening balance due to adoption of fair value measurement of digital assets			30,600		30,600
Issuance of common stocks pursuant to private placement	$ 5,100	6,533,900			6,539,000
Issuance of common stocks pursuant to private placement (in Shares)	5,079,999
Net loss			(1,089,500)	(147,400)	(1,236,900)
Balance at Mar. 31, 2023	$ 31,600	27,906,000	(14,479,300)	(1,163,700)	12,294,600
Balance (in Shares) at Mar. 31, 2023	31,564,054
Balance at Dec. 31, 2023	$ 31,800	27,822,200	(17,454,200)		10,399,800
Balance (in Shares) at Dec. 31, 2023	31,724,631
Issuance of common stocks to certain investors in a private placement	$ 2,500	3,732,500			3,735,000
Issuance of common stocks to certain investors in a private placement (in Shares)	2,490,000
Issuance of common stocks to an underwriter	$ 100	(100)
Issuance of common stocks to an underwriter (in Shares)	124,000
Issuance of common stocks to acquire a subsidiary	$ 1,500	2,263,500		1,510,000	3,775,000
Issuance of common stocks to acquire a subsidiary (in Shares)	1,500,000
Share-based compensation	$ 100	361,000			361,100
Share-based compensation (in Shares)	102,000
Net loss			(866,800)	(1,068,900)	(1,935,700)
Balance at Mar. 31, 2024	$ 36,000	$ 34,179,100	$ (18,321,000)	$ 441,100	$ 16,335,200
Balance (in Shares) at Mar. 31, 2024	35,940,631